Bladder cancer: Race differences in extent of disease at diagnosis

Cancer

Volumn 89, Issue 6, 2000, Pages 1349-1358

  Prout Jr , George R ^a   Wesley, Margaret N ^b   Greenberg, Raymond S ^c   Chen, Vivien W ^d   Brown, Charles C ^a   Miller, Alex W ^e   Weinstein, Ronald S ^f   Robboy, Stanley J ^g   Haynes, M Alfred ^a   Blacklow, Robert S ^h   Edwards, Brenda K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Advocate Good Samaritan Hospital   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g DUKE UNIVERSITY   (United States)

^h NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Bladder cancer; Cancer registry; Grade; Race; Sociodemographic factors; Stage

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CAUCASIAN; CONTROLLED STUDY; FEMALE; HEREDITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SMOKING; SOCIAL STATUS; UNITED STATES;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARCINOMA, TRANSITIONAL CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SMOKING; SOCIOECONOMIC FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0034666427     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000915)89:6<1349::AID-CNCR20>3.0.CO;2-D     Document Type: Article

References (59)

1. Transitional cell neoplasms of the urinary bladder: Can biologic potential be predicted from histologic grading?
2. Treated history of noninvasive Grade 1 transitional cell carcinoma
3. Ta and T1 bladder cancer: Location, recurrence and progression
4. The significance of lamina propria invasion on the prognosis of patients with bladder tumors
5. Stage T1 bladder cancer: Grade is the primary determinant for risk of muscle invasion
6. Carcinoma-in-situ of the urothelium
7. Long-term effect of intravesical bacillus Calmette-Guerrin on flat carcinoma in-situ of the bladder
8. The outcome of conservative treatment of carcinoma in-situ of the bladder
9. Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: Ten-year follow-up of a prospective randomized trial
10. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee
11. Urothelial papilloma of the bladder: Clinical and biologic implications
12. Papillary urothelial neoplasms of low malignant potential: Clinical and biologic implications
13. Bladder cancer redefined
14. Recurrence and progression in low grade papillary urothelial tumors
15. Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastases
16. Longitudinal study of patients with bladder cancer: Factors associated with disease recurrence and progression
17. Bladder cancer as a systemic disease
18. Mode of presentation of invasive bladder cancer: Reassessment of the problem
19. Muscle invasive bladder cancer: Does it arise de novo or from pre-existing superficial disease?
20. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome
21. Bladder cancer survival statistics
22. Urinary bladder
23. A collaborative study of differences in the survival rates of black patients and white patients with cancer
24. Poverty income guidelines: Annual revision
25. Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure
26. Toward a clearer definition of confounding
27. Black/white differences in bladder cancer patient survival
28. Black/white differences in non-treatment of bladder patients and implications for survival
29. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986
30. Socioeconomic differences in cancer survival
31. Delay in treating bladder tumors
32. The dangers of a long urological waiting list
33. Presenting symptoms, treatment delay and survival in bladder cancer
34. Time lag to diagnosis of bladder cancer: Influence of psychosocial parameters and level of health-care provision
35. Symptomatology
36. Endometrial cancer: Stage at diagnosis and associated factors in black and white patients
37. Breast cancer: Factors associated with stage at diagnosis in black and white women
38. Socioeconomic inequalities in health: No easy solution
39. The association of smoking with cancer of the urinary bladder in humans
40. An epidemiological investigation of cancer of the bladder
41. Smoking and cancer of the lower urinary tract
42. Tobacco smoking, occupational exposure, and bladder cancer in Argentina
43. Tobacco and bladder cancer in males: Increased risk for inhalers and black tobacco smokers
44. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder
45. Are the known bladder cancer risk-factors associated with more advanced bladder cancer?
46. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis
47. Chemical studies on tobacco smoke LXIV: On the analysis of aromatic amines in cigarette smoke
48. The role of N-acetyltransferase in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
49. Epidemiological Models of Carcinogenesis: The example of bladder cancer
50. DNA chips: State-of-the-art